Nexalin Therapy for the Treatment of Depressive Symptoms
Phase 2
Completed
- Conditions
- Depression
- Interventions
- Device: Nexalin 1.3mA DeviceDevice: Nexalin 15mA deviceDrug: placebo device and Citalopram
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2008-10-17
- Lead Sponsor
- Kalaco Scientific, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT00774813
- Locations
- 🇷🇺
Leningrad Regional Center of Addiction, Leningrad, Vsevolozhsky District, Russian Federation
🇷🇺St. Petersburg City Center of Neuroses, St. Petersburg, Russian Federation
© Copyright 2025. All Rights Reserved by MedPath